Показать сокращенную информацию
dc.contributor.author | Taran, O. | en |
dc.contributor.author | Konkov, D. | en |
dc.contributor.author | Yaremchuk, L. | en |
dc.contributor.author | Lobastova, T. | en |
dc.contributor.author | Zhuk, S. | en |
dc.date.accessioned | 2024-10-14T09:34:11Z | en |
dc.date.available | 2024-10-14T09:34:11Z | en |
dc.date.issued | 2024 | |
dc.identifier.citation | Taran. O. The effective preventive management for nausea and vomiting in pregnancy and hyperemesis gravidarum [Електронний ресурс] : poster review / O. Taran, D. Konkov, L. Yaremchuk [et al.] // XXIX Europian congress of perinatal medicine, 11-13 sep. 2024, Vienna. – Електрон. текст. дані. – Режим доступу: https://europerinatal.eu/congresses/ecpm-2024/ DOI: 10.13140/RG.2.2.23086.52802 | en |
dc.identifier.uri | https://dspace.vnmu.edu.ua/123456789/6614 | en |
dc.description.abstract | Nausea and Vomiting in Pregnancy (NVP) and Hyperemesis Gravidarum (HG) are prevalent yet frequently overlooked conditions during pregnancy. They impact 70-80% of pregnant women to varying degrees, with symptoms often extending beyond the first trimester. NVP affects up to 90% of pregnant women and is one of the most common indications for hospital admission among pregnant women, with typical stays of between three and four days. In a population based pregnancy cohort using general practice records prevalence of clinically recorded NVP/HG was 9.1%: 2.1% had hospital admissions, 3.4% were treated with antiemetics in primary care only, and 3.6% had only recorded diagnoses. | en |
dc.language.iso | en | en |
dc.subject | nausea and vomiting in pregnancy | en |
dc.subject | hyperemesis gravidarum | en |
dc.subject | psychological support | en |
dc.subject | diet | en |
dc.subject | acupuncture/acupressure | en |
dc.subject | ginger | en |
dc.subject | pyridoxine | en |
dc.title | The effective preventive management for nausea and vomiting in pregnancy and hyperemesis gravidarum | en |
dc.type | Presentation | en |